TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Shandong Weigao Group Medical Polymer Co ( (HK:1066) ) has issued an announcement.
Shandong Weigao Group Medical Polymer Company Limited has announced an extraordinary general meeting to be held on December 17, 2025, to discuss and approve several key resolutions. These include the approval of the Purchase Framework Agreement and the Logistic Support Services Framework Agreement, the reappointment of Mr. Li Qiang as an independent non-executive director, and a change in the company type. These resolutions are expected to impact the company’s operational strategies and governance structure.
The most recent analyst rating on (HK:1066) stock is a Hold with a HK$6.50 price target. To see the full list of analyst forecasts on Shandong Weigao Group Medical Polymer Co stock, see the HK:1066 Stock Forecast page.
More about Shandong Weigao Group Medical Polymer Co
Shandong Weigao Group Medical Polymer Company Limited is a joint stock limited company incorporated in the People’s Republic of China. The company operates in the medical polymer industry, focusing on the production and distribution of medical devices and related products.
Average Trading Volume: 17,066,805
Technical Sentiment Signal: Sell
Current Market Cap: HK$25.1B
For a thorough assessment of 1066 stock, go to TipRanks’ Stock Analysis page.